HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Health, Beauty And Wellness News: Nutrisystem Adds Options, Roar Gains $5.6M, SynTech Elite In US, More News

Executive Summary

Nurtisystem launches FreshStart, South Beach Keto; Roar Beverage $5.6m funding led by AccelFoods; SynTech brings Elite Series to US; ChromaDex extends Tru Niagen to Canada with Fullscript; Nugenix Sexual Vitality Booster with Nitrosigine; Abattis debuts Vergence Naturals with Comfort; Brueggman takes Vitaquest helm; and CBD Bath Soaks from allitom.

You may also be interested in...

ChromaDex Business Blooms After Pulling Niagen Claims Under NAD Review

Since Council of Better Business Bureaus investigators in May 2018 asked about claims for Tru Niagen, ChromaDex pulled the ads while reaching milestones in product distribution and ingredient licensing.

Wellness New Product Roundup: 'The Truth' CBD, Hilo Performance Gummies, Syntech Offers More In US

Wakunaga expands Kyo-Dophilus probiotic line; Avadim Health's Theraworx reaches pharmacies; Naturade expands VeganSmart line; Goodbye UTI supplement contains d-mannose; Hilo Nutrition workout gummies alternative to powders, liquids; Syntech Nutrition adds to US distribution; and former NBA great Paul Pierce enters wellness business with cannabidiol oils, vaporizers.

Products Provider Nutrisystem Moves To Fitness Services Firm Tivity For $1.4Bn

Nutrisystem's sale to Tivity Health comes after a year of expanding its nutritional products and related services with daily vitamin packs, nutritional bars and shakes and genetic-based analysis for a personal action plan focused on eating behaviors, nutrition and metabolism. Tivity's move into providing products, though, didn’t go over well with investors.


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts